CTNNB1 has been shown to play an important role in regulation of cell adhesion and gene transcription, and its deregulation has been associated with many cancers.34 Thus, CTNNB1 inhibitors are useful in treatment of many cancers including APC mutant cancers. Here, APC is linked to cancer.